Chestnut Hill, MA, United States of America

Susan Lindquist

USPTO Granted Patents = 35 (Patent Applications = 15)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 131(Granted Patents)

Location History:

Chicago, IL (US) (1998 - 2010)
Chestnut Hill, MA (US) (2006 - 2021)
Cambridge, MA (US) (2016 - 2022)
Brookline, MA (US) (2024)

Company Filing History:

29 out of 303

Whitehead Institute for Biomedical Research

patents

4 out of 917

The University of Chicago

patents

4 out of 8,375

Massachusetts Institute of Technology

patents

4. 3 out of 2,104

University of Washington

patents

5. 2 out of 444

The Broad Institute, Inc.

patents

6. 2 out of 349

Arch Development Corporation

patents

7. 2 out of 873

University of Missouri

patents

8. 2 out of 1,373

The Brigham and Women's Hospital, Inc.

patents

9. 1 out of 3

Foldrx Pharmaceuticals, Inc.

patents

10. 1 out of 2,893

The General Hospital Corporation

patents

where one patent can have more than one assignee

Years Active: 1998-2024

Loading Chart...

35 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12068059 - Methods for building genomic networks and uses thereof (2024-08-20),

2. 11261453 - Cells expressing apolipoprotein E and uses thereof (2022-03-01),

3. 11092602 - Methods and compositions relating to proteasome inhibitor resistance (2021-08-17),

4. 11047848 - Cellular discovery platform for neurodegenerative diseases (2021-06-29),

5. 10526651 - Modulators of alpha-synuclein toxicity (2020-01-07),

6. 10428335 - Yeast cells expressing TAR DNA-binding protein 43 and uses therefor (2019-10-01),

7. 10240160 - Yeast cells expressing amyloid beta and uses therefor (2019-03-26),

8. 10106803 - Yeast cells expressing TAR DNA-binding protein 43 and uses therefor (2018-10-23),

9. 9944607 - Thiohydantoin derivatives and uses thereof (2018-04-17),

10. 9909160 - Modulators of alpha-synuclein toxicity (2018-03-06),

11. 9879257 - Modulators of alpha-synuclein toxicity (2018-01-30),

12. 9822156 - Amyloid beta expression constructs and uses therefor (2017-11-21),

13. 9790188 - Benzimidazole derivatives and uses thereof (2017-10-17),

14. 9746470 - Chaperone interaction assays and uses thereof (2017-08-29),

15. 9738898 - Yeast cells expressing TAR DNA-binding protein 43 and uses therefor (2017-08-22),

Title: The Innovative Journey of Susan Lindquist

Introduction: Susan Lindquist, a pioneering female inventor hailing from Chestnut Hill, MA (US), made significant contributions to the field of science and innovation through her groundbreaking work in biochemistry and molecular biology.

Latest Patents: Susan Lindquist held several patents related to her research in protein folding, prion biology, and neurodegenerative diseases, showcasing her commitment to advancing scientific knowledge and technology.

Career Highlights: Throughout her illustrious career, Susan Lindquist served as a Professor of Biology at the Massachusetts Institute of Technology (MIT) and was the Director of the Whitehead Institute for Biomedical Research. Her research focused on understanding protein folding and its implications for various diseases.

Collaborations: Susan Lindquist collaborated with numerous scientists, researchers, and institutions worldwide to further explore the intricate mechanisms of protein folding and its role in health and disease. Her collaborative efforts led to groundbreaking discoveries in the field of molecular biology.

Conclusion: Susan Lindquist's innovative spirit, dedication to scientific exploration, and pioneering research in biochemistry have left an indelible mark on the scientific community. Her legacy continues to inspire future generations of inventors and researchers to push the boundaries of knowledge and innovation.

This text is generated by artificial intelligence and may not be accurate.